interviews David C. Brodner, MD.

These latest findings provide further confirmation of the potential for nonprescription REMfresh to help address the public health issue of the cumulative effects of sleep loss. Based on a novel Ion Powered Pump® (IPP®) delivery system that provides a pharmacokinetic (PK) profile that more closely aligns with the body’s own natural sleep pattern, REMfresh has demonstrated once again promising results and high levels of satisfaction in a real-world population of patients who have had chronic difficulties sleeping, providing up to seven hours of sleep support.

Get the full story at